3-nitropropionic acid has been researched along with tiagabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araujo, DM; Hilt, DC | 1 |
| Akula, KK; Dhir, A; Kulkarni, SK | 1 |
2 other study(ies) available for 3-nitropropionic acid and tiagabine
| Article | Year |
|---|---|
Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid.
Topics: Animals; Autoradiography; Choline O-Acetyltransferase; Female; Glial Cell Line-Derived Neurotrophic Factor; Injections, Intraventricular; Mitochondria; Motor Activity; Neostriatum; Nerve Growth Factors; Nerve Tissue Proteins; Neuropeptides; Neuroprotective Agents; Neurotoxins; Nipecotic Acids; Nitro Compounds; Propionates; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, GABA; Substantia Nigra; Tiagabine | 1998 |
Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
Topics: Animals; Behavior, Animal; Brain Chemistry; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; GABA Agonists; Glutathione; Huntington Disease; Lipid Peroxidation; Male; Memory Disorders; Motor Activity; Nipecotic Acids; Nitro Compounds; Nitroprusside; Propionates; Rats; Rats, Wistar; RNA; Rotarod Performance Test; Tiagabine | 2008 |